5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro

Abstract The coronavirus disease 2019 (COVID 19) pandemic continues to pose a threat to global health. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant (B.1.1.529) has spread rapidly worldwide and became dominant in many countries. A natural 5-aminolevulinic acid (5-A...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mya Myat Ngwe Tun, Takaya Sakura, Yasuteru Sakurai, Yohei Kurosaki, Daniel Ken Inaoka, Norifumi Shioda, Chris Smith, Jiro Yasuda, Kouichi Morita, Kiyoshi Kita
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2022-04-01
Colecção:Tropical Medicine and Health
Assuntos:
SARS-CoV-2
Omicron variant
5-ALA
SFC
Antiviral activity
Acesso em linha:https://doi.org/10.1186/s41182-022-00422-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados